Please Wait
Applying Filters...
menu
    • menu
    Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

    Stock Recap
    #PipelineProspector

    Menu

    Sodium Hyaluronate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 458Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name MF Registration No. Classification Initial Date of Reg. Latest Date of Reg. Registrant's Address
    26/09/2024 Bloomage Biotechnology Corp., Ltd
    China
    		 Bloomage Biotechnology Corp. , Ltd. 304MF10049 Purified sodium hyaluronate JP-AE 2022-03-02 2024-02-07 No. 678 Tianchen St. , High-Tech Development Zone, Jinan 250101 P. R. China
    26/09/2024 Kewpie Corporation
    Japan
    		 Kewpie Corporation 228MF10141 Hyaluronic acid HA-SHL 2016-08-02 2016-08-02 Shibuya 1-4-13, Shibuya-ku, Tokyo